A vaccine committee advisory to scrap routine hepatitis B shots for all newborns has sparked controversy among health experts, despite nearly eliminating early childhood infections in the US over the past three decades.
Before 1991, nearly 18,000 American children would contract hepatitis B every year, with half of them infected at birth. The vaccine's introduction drastically reduced this number, with fewer than 20 babies per year now reported to be infected at birth. However, experts are now being advised to consult their healthcare provider if a child is not born to an infected mother.
Pediatricians and health advocates argue that vaccinating newborns against hepatitis B remains one of the most evidence-based ways to protect children from this lifelong and deadly infection. The US adopted universal vaccination in 1991 due to the relatively high prevalence of hepatitis B infections and the fact that many mothers do not receive prenatal care, making screenings less effective.
The hepatitis B vaccine has an outstanding safety record, with only a rare allergic reaction reported in doses administered to billions of infants at birth. Extensive studies have shown no link between the vaccine and other serious conditions.
However, the new recommendation introduces uncertainty into a previously clear guideline, leading to concerns that parents may be misled and delay vaccination. The US has one of the highest rates of hepatitis B-related liver cancer and death among children in the world.
Experts warn that if only newborns born to infected mothers receive the vaccine, hundreds more cases would occur each year. The full three-dose vaccine series is essential for protection against hepatitis B, which can be transmitted through household contacts or child care settings via ordinary exposures such as shared toothbrushes or a bite that breaks the skin.
The change in recommendation has sparked debate over whether it's based on new evidence or introduces unnecessary uncertainty into a clear guideline. As one doctor noted, she is already seeing parents asking to postpone vaccination due to misinformation about transmission risks.
Before 1991, nearly 18,000 American children would contract hepatitis B every year, with half of them infected at birth. The vaccine's introduction drastically reduced this number, with fewer than 20 babies per year now reported to be infected at birth. However, experts are now being advised to consult their healthcare provider if a child is not born to an infected mother.
Pediatricians and health advocates argue that vaccinating newborns against hepatitis B remains one of the most evidence-based ways to protect children from this lifelong and deadly infection. The US adopted universal vaccination in 1991 due to the relatively high prevalence of hepatitis B infections and the fact that many mothers do not receive prenatal care, making screenings less effective.
The hepatitis B vaccine has an outstanding safety record, with only a rare allergic reaction reported in doses administered to billions of infants at birth. Extensive studies have shown no link between the vaccine and other serious conditions.
However, the new recommendation introduces uncertainty into a previously clear guideline, leading to concerns that parents may be misled and delay vaccination. The US has one of the highest rates of hepatitis B-related liver cancer and death among children in the world.
Experts warn that if only newborns born to infected mothers receive the vaccine, hundreds more cases would occur each year. The full three-dose vaccine series is essential for protection against hepatitis B, which can be transmitted through household contacts or child care settings via ordinary exposures such as shared toothbrushes or a bite that breaks the skin.
The change in recommendation has sparked debate over whether it's based on new evidence or introduces unnecessary uncertainty into a clear guideline. As one doctor noted, she is already seeing parents asking to postpone vaccination due to misinformation about transmission risks.